US firm De Novo Ventures closes $300m life science fund | AltAssets Private Equity News

Subscribe today

Advanced
Search

US firm De Novo Ventures closes $300m life science fund

23 Aug 2006

Menlo Park, California-based venture capital firm De Novo Ventures has closed its third venture fund, De Novo Ventures III, on $300m. The new fund will invest in medical device and in biotech companies with initial human clinical experience.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.